X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs AJANTA PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA AJANTA PHARMA SANOFI INDIA/
AJANTA PHARMA
 
P/E (TTM) x 34.3 19.4 176.5% View Chart
P/BV x 6.9 4.5 154.4% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SANOFI INDIA   AJANTA PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
AJANTA PHARMA
Mar-18
SANOFI INDIA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,5601,818 250.8%   
Low Rs4,4001,106 397.8%   
Sales per share (Unadj.) Rs1,028.5239.5 429.5%  
Earnings per share (Unadj.) Rs129.052.8 244.3%  
Cash flow per share (Unadj.) Rs186.059.5 312.5%  
Dividends per share (Unadj.) Rs68.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs753.6230.0 327.7%  
Shares outstanding (eoy) m23.0388.77 25.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.46.1 71.3%   
Avg P/E ratio x34.727.7 125.4%  
P/CF ratio (eoy) x24.124.6 98.0%  
Price / Book Value ratio x5.96.4 93.5%  
Dividend payout %52.70-   
Avg Mkt Cap Rs m103,174129,782 79.5%   
No. of employees `0003.66.8 53.3%   
Total wages/salary Rs m3,5923,765 95.4%   
Avg. sales/employee Rs Th6,537.73,128.4 209.0%   
Avg. wages/employee Rs Th991.4554.0 178.9%   
Avg. net profit/employee Rs Th819.8689.7 118.9%   
INCOME DATA
Net Sales Rs m23,68621,258 111.4%  
Other income Rs m708242 293.0%   
Total revenues Rs m24,39421,499 113.5%   
Gross profit Rs m5,2816,584 80.2%  
Depreciation Rs m1,313596 220.3%   
Interest Rs m154 365.9%   
Profit before tax Rs m4,6616,226 74.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6911,539 109.9%   
Profit after tax Rs m2,9704,686 63.4%  
Gross profit margin %22.331.0 72.0%  
Effective tax rate %36.324.7 146.7%   
Net profit margin %12.522.0 56.9%  
BALANCE SHEET DATA
Current assets Rs m15,67312,236 128.1%   
Current liabilities Rs m6,6783,461 193.0%   
Net working cap to sales %38.041.3 92.0%  
Current ratio x2.33.5 66.4%  
Inventory Days Days7660 126.2%  
Debtors Days Days2284 26.4%  
Net fixed assets Rs m8,09811,140 72.7%   
Share capital Rs m230177 130.2%   
"Free" reserves Rs m17,08820,237 84.4%   
Net worth Rs m17,35620,414 85.0%   
Long term debt Rs m010 0.0%   
Total assets Rs m25,40024,486 103.7%  
Interest coverage x311.71,519.4 20.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.9 107.4%   
Return on assets %11.819.2 61.3%  
Return on equity %17.123.0 74.5%  
Return on capital %26.930.5 88.3%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627NA-   
Fx inflow Rs m7,14511,667 61.2%   
Fx outflow Rs m6,8461,616 423.8%   
Net fx Rs m29910,052 3.0%   
CASH FLOW
From Operations Rs m3,2262,854 113.0%  
From Investments Rs m-1,555-2,604 59.7%  
From Financial Activity Rs m-1,818-2 90,900.0%  
Net Cashflow Rs m-147248 -59.3%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 1.6 929.0%  
FIIs % 14.6 7.6 192.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 17.0 61.8%  
Shareholders   15,184 20,968 72.4%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 22, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - IPCA LABS COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS